【昊海生物科技:9月10日回购4.8万股H股股份】昊海生物科技公告称,公司于2026年9月10日通过香港联交所回购H股股份48000股,每股回购价区间为16.47港元-16.76港元,回购总金额为795745港元,占有关事件前已发行H股股份的0.0213%。本次回购股份拟注销,截至2026年9月10日尚未注销。公司回购授权于2026年5月29日获批,可回购H股总数上限为3478034股,截至目前已累计回购807500股,占授权获批日已发行H股的2.3217%。本次回购后新股发行等事项暂止期至2026年10月10日。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.